ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB379

Association of Symptoms with Kidney Function and Sociodemographic Factors in Nondialysis-Dependent CKD

Session Information

Category: CKD (Non-Dialysis)

  • 2302 CKD (Non-Dialysis): Clinical, Outcomes, and Trials

Authors

  • Patel, Dipal M., The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
  • Han, Dingfen, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States
  • Riekert, Kristin, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
  • Shin, Jung-Im, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States
  • Crews, Deidra C., The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Background

Determinants and distribution of symptoms in people with non-dialysis-dependent CKD (CKD-ND) are not well known. We hypothesized that symptom burden is associated with kidney function and sociodemographic factors.

Methods

We evaluated data from a cohort of patients with CKD-ND who completed an electronic patient-reported outcome measure (ePROM) as part of routine nephrology care. Linear regression was used to assess associations of kidney function and sociodemographic factors with symptoms.

Results

Among 956 patients with CKD-ND, perceptions of health were variable (Figure 1). Advanced CKD stages (G4-G5) were associated with significantly worse patient-reported general health, QoL, and symptoms (Figure 2). Residence in regions of greater socioeconomic deprivation was associated with worse patient-reported general health; otherwise, ePROM scores were not significantly associated with sociodemographic factors.

Conclusion

For people with CKD-ND, symptoms are prevalent. Advanced CKD stage was associated with worse perceived general health, QoL, and symptom burden. Data highlight the need to assess patient-reported outcomes in patients with CKD-ND.

Figure 1: Distribution of ePROM scores.

Figure 2: Association of ePROM scores with patient characteristics, after adjustment for age and sex. Higher ADI quartiles indicate residence in regions with greater socioeconomic deprivation.

Funding

  • Other NIH Support

Digital Object Identifier (DOI)